• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Type One

To add a bio or update investment portfolio click update information.

Investment Portfolio

    BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in spaceBioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space
    BioOrbit
    30 Apr 2026

    BioOrbit lands a £9.8m seed round co-led by LocalGlobe and Breega to manufacture pharmaceutical drugs in space

    BioOrbit develops in-space manufacturing technology that produces biological drugs using microgravity. Its system enables drug formulations that can be self-administered, reducing the need for hospital-based intravenous treatment.

Type One
    • Life Sciences
  • 1(12 months)
  • type1ventures.com
  • Update Information

More venture news

  • DITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements
    DITTO
    28 Jul 2026

    DITTO lands a £4.5m seed round led by FoodLabs to develop evidence-based menstrual health supplements

    SeedHealth
  • Agon emerges from stealth with a £22m seed round from VCs to build synthetic battlefields that train AI defence systems
    Agon
    29 Jul 2026

    Agon emerges from stealth with a £22m seed round from VCs to build synthetic battlefields that train AI defence systems

    SeedDefence
  • ETN unlocks a £1.2m seed round led by Powerhouse Capital to broadcast Europe's first daily live tech news show
    etn.
    27 Jul 2026

    ETN unlocks a £1.2m seed round led by Powerhouse Capital to broadcast Europe's first daily live tech news show

    SeedMedia & Entertainment

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn